Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan PK interaction with Rifampicin in healthy women
NCT02975440Phase 1Completed
- Sponsor
- Bayer
- Start
- Nov 2016
- Primary completion
- Jan 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vilaprisan in endometriosis, sponsored by Bayer. Primary endpoints: Area Under the Curve of Vilaprisan with Rifampicin up to 14 days, Maximum Plasma Concentration of Vilaprisan with Rifampicin up to 14 days and 2 more. Started Nov 2016; status: completed.
02
Drugs
vilaprisan
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02975440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975440.